Integrin-linked kinase pathway is also responsible for EMT in ovarian cancer induced by endothelin, and combined targeting of endothelin receptor and EGF receptors has shown enhanced antitumour activity in ovarian cancers (Bagnato and Rosanò, 2007; Rosanò et al, 2007). Here, ILK is linked to ovarian cancer.